Jakob Brix Christensen

Chief Executive Officer at Unibio AS

Health Technology

Process Industries

Profile

Jakob Brix Christensen is currently the Co-Chief Executive Officer at Unibio.
AS since 2021.
Prior to this, he worked as the Director-Investor Relations at Origio A from 2007 to 2012, Senior Manager-Business Finance at Novozymes A from 2012 to 2013, Partner-Business Finance at Albumedix A from 2013 to 2015, and Chief Financial Officer at Bioporto A from 2016 to 2018.

Jakob Brix Christensen active positions

Companies	Position	Start
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Chief Executive Officer	26/06/2021

All active positions of Jakob Brix Christensen

Former positions of Jakob Brix Christensen

Companies	Position	End
BIOPORTO A/S	Director of Finance/CFO	31/05/2018
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Corporate Officer/Principal	30/11/2015
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	31/03/2013
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Public Communications Contact	31/03/2012

See the detail of Jakob Brix Christensen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jakob Brix Christensen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BIOPORTO A/S	Health Technology

Private companies	4
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Process Industries
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Health Technology
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Health Technology
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Health Technology

See company connections